| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Grossman Adam S | President and CEO, Director | C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY | /s/ Adam S. Grossman, by Michael A. Goldstein as Attorney-in-fact | 10 Mar 2026 | 0001542517 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ADMA | Common Stock | Tax liability | -56,438 | -2.6% | $15.39* | 2,148,290 | 06 Mar 2026 | Direct | F1 | |
| transaction | ADMA | Common Stock | Tax liability | -29,513 | -1.4% | $15.39* | 2,118,777 | 07 Mar 2026 | Direct | F1, F2, F3, F4 | |
| holding | ADMA | Common Stock | 1,143,426 | 06 Mar 2026 | See Footnote | F5 | |||||
| holding | ADMA | Common Stock | 580,957 | 06 Mar 2026 | See Footnote | F6 |
| Id | Content |
|---|---|
| F1 | Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units ("RSUs"). This is not an open market sale of securities. |
| F2 | Includes, as of the transaction date, (i) 282,529 unvested RSUs granted on February 9, 2026, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (ii) 189,017 unvested RSUs out of 252,022 RSUs granted on February 19, 2025, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; |
| F3 | (continued from footnote 2) (iii) 278,864 unvested RSUs out of 557,728 RSUs granted on February 26, 2024, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (iv) 143,424 unvested RSUs out of 573,695 RSUs granted on March 6, 2023 that will vest quarterly on each annual anniversary of the date of grant, over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; |
| F4 | (continued from footnote 3) and (v) 1,224,943 shares of common stock owned by the Reporting Person, which reflects prior purchases and the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes. |
| F5 | These shares are owned by Areth, LLC ("Areth"). The Reporting Person is a control person of Areth. |
| F6 | These shares are owned by Hariden, LLC ("Hariden"). The Reporting Person is the managing member of Hariden. |